Analyst Ratings for Galectin Therapeutics (GALT)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2025 | H.C. Wainwright | Matthew Keller | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.49 (2.83) |
89.93% | Details |
| 2/13/2019 | B.Riley » Updated 4/3/2020 |
Mayank Mamtani | New Coverage | Buy (N/A) |
4.00 (8.00) |
4.14 (2.83) |
-31.64% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


